Current status and future prospects for disease modification in osteoarthritis.

about

Current status and future prospects for disease modification in osteoarthritis.

Item

http://www.wikidata.org/entity/Q47570656

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Current status and future prospects for disease modification in osteoarthritis.

@en

Current status and future prospects for disease modification in osteoarthritis.

@nl

type

Item

label

Current status and future prospects for disease modification in osteoarthritis.

@en

Current status and future prospects for disease modification in osteoarthritis.

@nl

prefLabel

Current status and future prospects for disease modification in osteoarthritis.

@en

Current status and future prospects for disease modification in osteoarthritis.

@nl

P1476

Current status and future prospects for disease modification in osteoarthritis

@en

P2093

Shirley Pei-Chun Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases.

Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]

Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO

Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis

Viscosupplementation for Osteoarthritis of the Knee

Strontium ranelate, a promising disease modifying osteoarthritis drug.

P304

iv108-iv123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1093/RHEUMATOLOGY/KEX496

http://www.w3.org/2001/XMLSchema#string

P433

suppl_4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Changhai Ding

Zhengping Huang

T Li

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29272498

http://www.w3.org/2001/XMLSchema#string

P921

osteoarthritis